Shanghai Ark Biopharmaceutical Co., Ltd announced today that China’s National Medical Products Administration (NMPA) has cleared the Investigational New Drug (IND) application for AK0406 injection, the company’s first antiviral drug-Fc …
Decoy Therapeutics Inc, a biotechnology company focused on developing Designable Multi-Antivirals (D-MAVs), has announced that one of its D-MAV candidates has demonstrated in vitro effectiveness against the wild-type Ebola Zaire …
Hyundai Bioscience has revealed an ambitious new plan aimed at addressing worldwide viral outbreaks, confirming the launch of its Phase 2 clinical trials in the United States. During its presentation …
Clover Biopharmaceuticals, Ltd, a global biotechnology company with commercial-stage operations and a focus on developing innovative vaccines to protect lives and enhance public health worldwide, has announced the completion of …
Like other groundbreaking technologies, artificial intelligence holds immense potential to reshape how we address some of the world’s most urgent problems. But to truly unlock its benefits, we must collaborate …
In 2019, 21-year-old Somchai from Thailand was dealing with two serious health conditions—he had both hepatitis B (HBV) and advanced HIV. “Because these two viruses are transmitted in similar ways …
In the early 2000s, Dr. Shannon Hader was instrumental in the collaboration between the U.S. Centers for Disease Control and Prevention and the Zimbabwe Ministry of Health, which successfully provided …
